Share-based Payment Arrangement, Expense of NKGen Biotech, Inc. from 30 Sep 2022 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
NKGen Biotech, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Sep 2022 to 31 Mar 2025.
  • NKGen Biotech, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Mar 2025 was $707,000, a 37% decline year-over-year.
  • NKGen Biotech, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 31 Mar 2025 was $3,732,000, a 6.6% decline year-over-year.
  • NKGen Biotech, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $4,142,000, a 0.17% increase from 2023.
  • NKGen Biotech, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $4,135,000, a 5893% increase from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

NKGen Biotech, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $3,732,000 $707,000 -$410,000 -37% 01 Jan 2025 31 Mar 2025 10-Q 20 Jan 2026 2025 Q1
Q4 2024 $4,142,000 $836,000 -$92,000 -9.9% 01 Oct 2024 31 Dec 2024 10-K 08 Oct 2025 2024 FY
Q3 2024 $4,234,000 $1,092,000 +$125,000 +13% 01 Jul 2024 30 Sep 2024 10-Q 04 Mar 2025 2024 Q3
Q2 2024 $4,109,000 $1,097,000 +$115,000 +12% 01 Apr 2024 30 Jun 2024 10-Q 12 Sep 2024 2024 Q2
Q1 2024 $3,994,000 $1,117,000 -$141,000 -11% 01 Jan 2024 31 Mar 2024 10-Q 20 Jan 2026 2025 Q1
Q4 2023 $4,135,000 $928,000 01 Oct 2023 31 Dec 2023 10-K 08 Oct 2025 2024 FY
Q3 2023 $967,000 +$951,000 +5944% 01 Jul 2023 30 Sep 2023 10-Q 04 Mar 2025 2024 Q3
Q2 2023 $982,000 01 Apr 2023 30 Jun 2023 10-Q 12 Sep 2024 2024 Q2
Q1 2023 $1,258,000 01 Jan 2023 31 Mar 2023 10-Q 20 May 2024 2024 Q1
Q3 2022 $16,000 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3

NKGen Biotech, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $4,142,000 +$7,000 +0.17% 01 Jan 2024 31 Dec 2024 10-K 08 Oct 2025 2024 FY
2023 $4,135,000 +$4,066,000 +5893% 01 Jan 2023 31 Dec 2023 10-K 08 Oct 2025 2024 FY
2022 $69,000 01 Jan 2022 31 Dec 2022 10-K 16 Apr 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.